Title : Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.

Pub. Date : 2013 Oct 1

PMID : 23631981






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A previous clinical trial studied the effect of long-term treatment with levodopa (LD) or the dopamine agonist pramipexole (PPX) on disease progression in Parkinson disease using SPECT with the dopamine transporter (DAT)-radioligand [(123)I]beta-CIT as surrogate marker. Levodopa solute carrier family 6 member 3 Homo sapiens
2 A previous clinical trial studied the effect of long-term treatment with levodopa (LD) or the dopamine agonist pramipexole (PPX) on disease progression in Parkinson disease using SPECT with the dopamine transporter (DAT)-radioligand [(123)I]beta-CIT as surrogate marker. Levodopa solute carrier family 6 member 3 Homo sapiens